Skip to search formSkip to main contentSkip to account menu

JTT 705

Known as: JTT-705, JTT705 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

dalcetrapib

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Pharmacokinetics and disposition of dalcetrapib in rats and monkeys
Abstract 1. The pharmacokinetics and metabolism of dalcetrapib (JTT-705/RO4607381), a novel cholesteryl ester transfer protein… 
Review
2012
Review
2012
Therapeutic targets to raise HDL in patients at risk or with coronary artery disease.
The plasma levels of high-density lipoprotein (HDL) cholesterol are inversely related to cardiovascular risk. Traditional HDL… 
2009
2009
Cholesterylestertransfer protein inhibition and endothelial function in type II hyperlipidemia.
2007
2007
Cholesteryl ester transfer protein promotes the formation of cholesterol-rich remnant like lipoprotein particles in human plasma.
Review
2006
Review
2006
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.
Review
2005
Review
2005
Increasing high-density lipoprotein cholesterol through cholesteryl Ester transfer protein inhibition: a next step in the fight against cardiovascular disease?
Over the past decades, lowering of LDL-cholesterol (LDL-c) levels has been established as the foundation for preventing… 
2004
2004
Inhibition of cholesteryl ester transfer protein increases serum apolipoprotein (apo) A-I levels by increasing the synthesis of apo A-I in rabbits.
Review
2004
Review
2004
Role of CETP inhibitors in the treatment of dyslipidemia
Purpose of review This review summarizes novel human data on cholesteryl ester-transfer protein (CETP) and atherosclerosis and… 
Highly Cited
2002
Highly Cited
2002
Effect of HDL, from Japanese white rabbit administered a new cholesteryl ester transfer protein inhibitor JTT-705, on cholesteryl ester accumulation induced by acetylated low density lipoprotein in…
Highly Cited
2000
Highly Cited
2000
bis(2-(Acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, and S-(2-(acylamino)phenyl) alkanethioates as novel inhibitors of cholesteryl ester transfer protein.
A series of bis(2-(acylamino)phenyl) disulfides, 2-(acylamino)benzenethiols, S-(2-(acylamino)phenyl) alkanethioates, and related… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)